AC Immune SA (ACIU)

NASDAQ: ACIU · USD

$2.34

+0.09 (+4.0%)· Recorded snapshot

Market cap	232.7M
Revenue (ttm)	21.7M
Net income (ttm)	-53.4M
EPS (ttm)	-$0.53
Shares out	99.4M
Volume	221,892
Beta	1.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.7M
Net income (ttm): -53.4M
EPS (ttm): -$0.53
Market cap: 232.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.5

P25 n/aP50 n/aP75 n/a

ROIC-45.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ACIU indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

CHF

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001651625
Company name	AC Immune SA
Country	Switzerland
Country code	US
CUSIP number	H00263105
Earnings date	2026-11-10
Earnings time	bmo
Employees	122
Employees change	-50
Employees growth	-29.07%
Enterprise value	$144.5M
Exchange	NASDAQ
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Biotechnology
IPO date	2016-09-23
Is primary listing	Yes
Is SPAC	No
ISIN number	CH0329023102
Last 10-K release date	2026-03-13
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$232.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$2.34
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ACIU
Website	https://www.acimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-22.49%
EV/Sales	6.25x
FCF / EV yield	-45.44%
FCF yield	-27.53%
Forward EV/Sales	14.77x
Forward P/S	24.38x
P/B ratio	5.14x
P/S ratio	10.32x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-249.58%
EBITDA margin	-242.61%
Gross margin	-162.23%
Operating margin	-249.58%
Pretax margin	-246.48%
Profit margin	-246.48%
Profit per employee	$-437,794
Profitable quarters	1
Revenue per employee	$177,619
ROA	-16.04%
ROA (5Y)	-19.18%
ROCE	-87.12%
ROE	-78.53%
ROE (5Y)	-45.56%
ROIC	-45.93%
SBC / revenue	24.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	3
Net income growth years	0
Revenue growth	-39.45%
Revenue growth (Q)	1,057.2%
Revenue growth (QoQ)	1,250.58%
Revenue growth 10Y	-9.04%
Revenue growth 3Y	64.48%
Revenue growth 5Y	53.33%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-715,970
Depreciation and amortization	$1.5M
EBIT	$-54.1M
EBITDA	$-52.6M
EPS	$-0.53
FCF per share	$-0.62
Financing cash flow	$-461,634
Free cash flow	$-61.6M
Free cash flow minus SBC	$-66.8M
Gross profit	$-35.2M
Investing cash flow	$65.9M
Net borrowing	$-1.2M
Net cash flow	$2.5M
Net income	$-53.4M
Operating cash flow minus SBC	$-66.1M
Operating income	$-54.1M
Revenue	$21.7M
Stock-based compensation	$5.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.94
Book value per share	$0.44
Debt / equity	0.12
Interest coverage	-204.2
Long-term assets	$73.6M
Long-term liabilities	$21.8M
Net cash (debt)	$88.2M
Net cash / market cap	39.42%
Net cash growth	-41.7%
Net debt / equity	-2.03
Piotroski F-Score	0
Property, plant and equipment	$7.2M
Shareholders' equity	$43.5M
Tangible book value	$-18.9M
Tangible book value per share	$-0.19
Total assets	$186.1M
Total cash	$93.3M
Total debt	$5.1M
Total liabilities	$142.6M
WACC	12.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.1
Current assets	$112.6M
Current liabilities	$120.8M
Current ratio	0.93
Net working capital	$-100.7M
Quick ratio	0.89
Working capital	$-8.5M
Working capital turnover	1.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.25%
Dividend yield	0%
Shareholder yield	-1.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-84.71%
10Y return CAGR	-17.12%
10Y total return	-84.71%
150-day SMA	$2.63
1D price change	4%
1M price change	-9.52%
1M total return	-9.52%
1W price change	-8.43%
1W total return	-8.43%
1Y price change	-36.49%
1Y return CAGR	-36.51%
1Y total return	-36.49%
20-day SMA	$2.48
200-day SMA	$2.74
3M price change	-0.87%
3M total return	-0.87%
3Y price change	-15.87%
3Y return CAGR	-5.6%
3Y total return	-15.87%
50-day SMA	$2.62
50-day SMA vs 200-day SMA	50under200
52-week high	$4.00
52-week high date	2025-10-29
52-week low	$2.03
52-week low date	2026-10-27
5Y price change	-64.26%
5Y return CAGR	-18.6%
5Y total return	-64.26%
6M price change	-19.72%
6M total return	-19.72%
All-time high	$19.97
All-time high date	2016-09-28
All-time low	$1.43
All-time low date	2025-04-09
Average true range (ATR)	$0.13
Average volume	207.4K
Beta (1Y)	0.57
Beta (2Y)	1.26
Beta (5Y)	1.55
Change from 52-week high	-41.5%
Change from 52-week low	15.27%
Change from all-time high	-88.58%
Change from all-time low	59.44%
Change from open	5.41%
Day's gap	-1.33%
Dollar volume	$519,227
High price	$2.34
Low price	$2.22
Monthly RSI	44.6
Open price	$2.22
Position in 52-week range	100%
Premarket change	0%
Premarket close	$2.25
Premarket price	$2.25
Previous close	$2.25
Price vs 150-day SMA	-13.14%
Price vs 20-day SMA	-8.1%
Price vs 200-day SMA	-16.79%
Price vs 50-day SMA	-13.11%
Relative volume	1.07
RSI	36.83
Sharpe ratio	-0.43
Sharpe ratio (3Y)	0.22
Sharpe ratio (5Y)	0.06
Sortino ratio	-0.53
Sortino ratio (3Y)	0.46
Sortino ratio (5Y)	0.19
Volume	221.9K
Weekly RSI	42.77
YTD price change	-27.39%
YTD total return	-27.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39.2M
Float percentage	39.41%
Shares change (QoQ)	6.67%
Shares change (YoY)	1.25%
Shares held by insiders	5.71%
Shares held by institutions	4.73%
Shares outstanding	99.4M
Short % of shares	7.59%
Short ratio	21.4 days

Deeper analysis on ACIU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ACIU report

Is a complete ACIU research report available?

No complete published report is available for AC Immune SA (ACIU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AC Immune SA (ACIU)

Price

Financial snapshot

Fair-value bridge

Latest news · ACIU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACIU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACIU

Frequently asked questions